These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 9607044

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.
    Wu HY, Russell MW.
    Infect Immun; 1993 Jan; 61(1):314-22. PubMed ID: 8418053
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.
    Harokopakis E, Hajishengallis G, Michalek SM.
    Infect Immun; 1998 Sep; 66(9):4299-304. PubMed ID: 9712781
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
    Martin M, Metzger DJ, Michalek SM, Connell TD, Russell MW.
    Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
    [Abstract] [Full Text] [Related]

  • 6. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.
    Russell MW, Moldoveanu Z, White PL, Sibert GJ, Mestecky J, Michalek S M.
    Infect Immun; 1996 Apr; 64(4):1272-83. PubMed ID: 8606090
    [Abstract] [Full Text] [Related]

  • 7. Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.
    Toida N, Hajishengallis G, Wu HY, Russell MW.
    Infect Immun; 1997 Mar; 65(3):909-15. PubMed ID: 9038296
    [Abstract] [Full Text] [Related]

  • 8. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M, Yasuda Y, Taniguchi T, Kozuka S, Matano K, Maeyama J, Morokuma K, Ohkuma K, Goto N, Tochikubo K.
    Vaccine; 2003 Mar 07; 21(11-12):1165-73. PubMed ID: 12559794
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.
    Russell MW, Wu HY.
    Infect Immun; 1991 Nov 07; 59(11):4061-70. PubMed ID: 1937766
    [Abstract] [Full Text] [Related]

  • 11. Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant.
    Isaka M, Yasuda Y, Mizokami M, Kozuka S, Taniguchi T, Matano K, Maeyama J, Mizuno K, Morokuma K, Ohkuma K, Goto N, Tochikubo K.
    Vaccine; 2001 Jan 08; 19(11-12):1460-6. PubMed ID: 11163669
    [Abstract] [Full Text] [Related]

  • 12. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
    Isaka M, Yasuda Y, Kozuka S, Miura Y, Taniguchi T, Matano K, Goto N, Tochikubo K.
    Vaccine; 1998 Oct 08; 16(17):1620-6. PubMed ID: 9713937
    [Abstract] [Full Text] [Related]

  • 13. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
    Shen X, Lagergård T, Yang Y, Lindblad M, Fredriksson M, Holmgren J.
    Vaccine; 2000 Nov 22; 19(7-8):850-61. PubMed ID: 11115709
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.
    Childers NK, Miller KL, Tong G, Llarena JC, Greenway T, Ulrich JT, Michalek SM.
    Infect Immun; 2000 Oct 22; 68(10):5509-16. PubMed ID: 10992447
    [Abstract] [Full Text] [Related]

  • 17. Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin.
    Katz J, Harmon CC, Buckner GP, Richardson GJ, Russell MW, Michalek SM.
    Infect Immun; 1993 May 22; 61(5):1964-71. PubMed ID: 8478086
    [Abstract] [Full Text] [Related]

  • 18. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M, Yasuda Y, Kozuka S, Taniguchi T, Matano K, Maeyama J, Komiya T, Ohkuma K, Goto N, Tochikubo K.
    Vaccine; 1999 Nov 12; 18(7-8):743-51. PubMed ID: 10547435
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
    Blanchard TG, Lycke N, Czinn SJ, Nedrud JG.
    Immunology; 1998 May 12; 94(1):22-7. PubMed ID: 9708182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.